Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LRRC8A Regulates Outer Hair Cell Volume and Electromotility and is Required for Hearing.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025
Same author

Repressor element 1-silencing transcription factor deficiency yields profound hearing loss through K<sub>v</sub>7.4 channel upsurge in auditory neurons and hair cells.

eLife·2022
Same author

Downregulation of REST in the cochlea contributes to age-related hearing loss via the p53 apoptosis pathway.

Cell death & disease·2022
Same author

Na<sup>+</sup> , K<sup>+</sup> -ATPase participates in the protective mechanism of rat cerebral ischemia-reperfusion through the interaction with glutamate transporter-1.

Fundamental & clinical pharmacology·2021
Same author

Are glutamate transporters neuroprotective or neurodegenerative during cerebral ischemia?

Journal of molecular medicine (Berlin, Germany)·2019

Related Experiment Video

Updated: Jun 25, 2026

AAV Systems and Mouse Models for Investigating Ectopic Expression of Neurod1 in Transduced Cells at Subacute and Chronic Times Post-Ischemic Stroke
05:40

AAV Systems and Mouse Models for Investigating Ectopic Expression of Neurod1 in Transduced Cells at Subacute and Chronic Times Post-Ischemic Stroke

Published on: November 29, 2024

NMDA Receptor-Targeted Neuroprotection in Ischemic Stroke: The 3S Framework Integrating Spatiotemporal Dynamics,

Lan Ma1, Yan-Nan Xu2, Xiao-Kun Mi3

  • 1Hebei Key Laboratory of Critical Disease Mechanism and Intervention, Department of Pathophysiology, Neuroscience Research Center; The Key Laboratory of Neural and Vascular Biology, Ministry of Education, Hebei Medical University, 361 Zhongshan East Road, Shijiazhuang 050017, China.

Current Neuropharmacology
|June 24, 2026
PubMed
Summary

A new framework explains why blocking all NMDA receptors (NMDARs) fails in stroke treatment, but targeting specific subtypes shows promise. This approach guides the development of precision neuroprotective strategies for ischemic stroke.

Keywords:
3S frameworkGluN2AGluN2BGluN2CGluN2DNMDA receptorischemic conditioningischemic strokenerinetidereceptor subtype selectivityremote ischemic postconditioningsexual dimorphism

More Related Videos

Induction of Acute Ischemic Stroke in Mice Using the Distal Middle Artery Occlusion Technique
07:34

Induction of Acute Ischemic Stroke in Mice Using the Distal Middle Artery Occlusion Technique

Published on: December 15, 2023

A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate
04:48

A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate

Published on: July 10, 2018

Related Experiment Videos

Last Updated: Jun 25, 2026

AAV Systems and Mouse Models for Investigating Ectopic Expression of Neurod1 in Transduced Cells at Subacute and Chronic Times Post-Ischemic Stroke
05:40

AAV Systems and Mouse Models for Investigating Ectopic Expression of Neurod1 in Transduced Cells at Subacute and Chronic Times Post-Ischemic Stroke

Published on: November 29, 2024

Induction of Acute Ischemic Stroke in Mice Using the Distal Middle Artery Occlusion Technique
07:34

Induction of Acute Ischemic Stroke in Mice Using the Distal Middle Artery Occlusion Technique

Published on: December 15, 2023

A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate
04:48

A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate

Published on: July 10, 2018

Area of Science:

  • Neuroscience
  • Pharmacology
  • Stroke Research

Background:

  • Ischemic stroke has limited therapeutic options beyond thrombolysis.
  • Complete NMDA receptor (NMDAR) blockade has failed clinically, creating a paradox in stroke neuropharmacology.

Purpose of the Study:

  • To propose a "Spatiotemporal-Subtype-Signaling (3S)" framework to resolve the paradox of NMDAR blockade in ischemic stroke.
  • To integrate spatiotemporal dynamics, NMDAR subtype selectivity, and signaling pathway selectivity.

Main Methods:

  • Analyzing NMDAR expression, phosphorylation, and localization shifts during stroke.
  • Differentiating effects of NMDAR subtypes (GluN2A, GluN2B, GluN2C/D) on neuronal fate.
  • Investigating NMDAR crosstalk with ferroptosis and sexual dimorphism in signaling pathways.

Main Results:

  • GluN2A promotes survival via PI3K-Akt-FOXO/GSK3β and ERK-CREB-BDNF pathways.
  • GluN2B mediates excitotoxicity via p38 MAPK, JNK, and PSD-95-nNOS.
  • Distinct sex-specific signaling pathways (estrogen receptor α, GPR30 in females).

Conclusions:

  • The 3S framework clarifies why complete NMDAR blockade fails and precision interventions may succeed.
  • Identifies priorities for sex-specific, subtype-targeted neuroprotective strategies in ischemic stroke.
  • Highlights translational potential of subtype-selective antagonists and protein-protein interaction disruptors.